Annual Report

Overview

The report describes ImmuneOnco's 2024 sustainability governance, including Board oversight and an ESG working group supporting implementation. It reports zero workplace fatalities for three consecutive years and total Scope 1 and Scope 2 emissions of 2,126.78 tonnes. The report also covers workforce diversity, employee welfare and training, responsible sourcing, healthcare accessibility, and community environmental and animal-welfare initiatives.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 25 March 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services